Get started
Abbott LaboratoriesAbbott LaboratoriesAbbott Laboratories

Abbott Laboratories

No trades
No trades
OverviewFinancialsDocumentsNewsCommunityTechnicalsForecastsSeasonalsOptionsETFsBonds

SEC filings and other documents


Explore the latest company documents and SEC filings from the company, including Forms 10-K, 10-Q, 8-K, and other key disclosures. Evaluate financial performance and operational updates to make more informed decisions.
2026
Earnings, Q2 FY2026
Jul 16, 2026
Q2 sales up 4.8%, EPS beats, guidance raised; strong growth in nutrition, diagnostics, and devices.
Earnings, Q1 FY2026
Apr 16, 2026
Q1 delivered solid growth and EPS, with Exact Sciences integration fueling diagnostics momentum.
2025
Earnings, Q4 FY2025
Annual
Jan 22, 2026
2026 outlook targets 10% EPS growth and 7% organic sales growth, driven by innovation and new launches.
Earnings, Q3 FY2025
Oct 15, 2025
Double-digit device growth and robust innovation drive strong sales and EPS momentum.
Earnings, Q2 FY2025
Jul 17, 2025
Strong Q2 growth and margin expansion, with guidance reaffirmed despite diagnostics headwinds.
Earnings, Q1 FY2025
Apr 16, 2025
Strong Q1 growth, margin expansion, and tariff mitigation support reaffirmed 2025 guidance.
2024
Earnings, Q4 FY2024
Annual
Jan 22, 2025
Double-digit EPS growth and robust sales momentum expected to continue in 2025.
Earnings, Q3 FY2024
Oct 16, 2024
Earnings, Q2 FY2024
Jul 18, 2024
Earnings, Q1 FY2024
Apr 17, 2024
J.P. Morgan 42nd Annual Healthcare Conference 2024
Jan 9, 2024
2023
Earnings, Q4 FY2023
Annual
Jan 24, 2024
Earnings, Q3 FY2023
Oct 18, 2023
Earnings, Q2 FY2023
Jul 20, 2023
Earnings, Q1 FY2023
Apr 19, 2023
JPMorgan Healthcare Conference
Jan 10, 2023
2022
Earnings, Q4 FY2022
Annual
Jan 25, 2023
Earnings, Q3 FY2022
Oct 19, 2022
Earnings, Q2 FY2022
Jul 20, 2022
Earnings, Q1 FY2022
Apr 20, 2022
2021
Earnings, Q4 FY2021
Annual
Jan 26, 2022
Earnings, Q3 FY2021
Oct 20, 2021
Earnings, Q2 FY2021
Jul 22, 2021
Updated Outlook 2021
Jul 1, 2021